These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


441 related items for PubMed ID: 17557890

  • 1. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
    Teixeira L, Mouthon L, Mahr A, Berezné A, Agard C, Mehrenberger M, Noël LH, Trolliet P, Frances C, Cabane J, Guillevin L, Group Français de Recherche sur le Sclérodermie (GFRS).
    Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ, Weisman MH, Seibold JR, Furst DE, Wong WK, Hurwitz EL, Mayes M, White B, Wigley F, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Clements PJ.
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.
    Steen VD, Medsger TA.
    Arthritis Rheum; 1998 Sep; 41(9):1613-9. PubMed ID: 9751093
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF, Pope JE, Ouimet JM.
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [Abstract] [Full Text] [Related]

  • 10. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.
    Joven BE, Almodovar R, Carmona L, Carreira PE.
    Semin Arthritis Rheum; 2010 Feb; 39(4):285-93. PubMed ID: 19782387
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk factors and outcome of Thai patients with scleroderma renal crisis: a disease duration-matched case control study.
    Wangkaew S, Lertthanaphok S, Puntana S, Noppakun K.
    Int J Rheum Dis; 2017 Oct; 20(10):1562-1571. PubMed ID: 28752678
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.
    Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen VD, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Furst DE.
    Arthritis Rheum; 2000 Nov; 43(11):2445-54. PubMed ID: 11083267
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis, management and prevention of scleroderma renal disease.
    Penn H, Denton CP.
    Curr Opin Rheumatol; 2008 Nov; 20(6):692-6. PubMed ID: 18946330
    [Abstract] [Full Text] [Related]

  • 18. [Scleroderma renal crisis].
    Morović-Vergles J, Culo MI, Kaliterna DM.
    Reumatizam; 2010 Nov; 57(2):109-11. PubMed ID: 21875014
    [Abstract] [Full Text] [Related]

  • 19. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
    Nihtyanova SI, Tang EC, Coghlan JG, Wells AU, Black CM, Denton CP.
    QJM; 2010 Feb; 103(2):109-15. PubMed ID: 19966313
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
    Vonk MC, Marjanovic Z, van den Hoogen FH, Zohar S, Schattenberg AV, Fibbe WE, Larghero J, Gluckman E, Preijers FW, van Dijk AP, Bax JJ, Roblot P, van Riel PL, van Laar JM, Farge D.
    Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.